Vivo Capital, LLC Cytom X Therapeutics, Inc. Transaction History
Vivo Capital, LLC
- $472 Million
- Q2 2025
A detailed history of Vivo Capital, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 5,769,230 shares of CTMX stock, worth $10.7 Million. This represents 2.77% of its overall portfolio holdings.
Number of Shares
5,769,230Holding current value
$10.7 Million% of portfolio
2.77%Shares
1 transactions
Others Institutions Holding CTMX
# of Institutions
73Shares Held
58.1MCall Options Held
8.9KPut Options Held
47.9K-
Vanguard Group Inc Valley Forge, PA9.38MShares$17.4 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.46MShares$15.7 Million0.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.08MShares$15 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY6.99MShares$13 Million0.7% of portfolio
-
Tang Capital Management LLC San Diego, CA6.72MShares$12.5 Million0.28% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $123M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...